From 2006 to 2010, Lloyd Jones was vice-president of finance at TransMolecular having spent the previous decade as a senior director of corporate development at Genzyme.
TetraLogic Pharmaceuticals, a US-based developer of anti-cancer drugs backed by pharmaceutical company Pfizer, has hired Jonathan Lloyd Jones as its chief financial officer and vice-president of corporate development after last month raising $6m in its extended series C round.
From 2006 to 2010, Lloyd Jones was vice-president of finance at TransMolecular having spent the previous decade as a senior director of corporate development at Genzyme.
In September, Pfizer through its corporate venturing unit invested $5m in TetraLogic.
Pfizer…
